BACKGROUND: While recent genome-wide association studies have identified several new bipolar disorder (BD) risk variants, structural imaging studies have reported enlarged ventricles and volumetric reductions among the most consistent findings. We investigated whether these genetic risk variants could explain some of the structural brain abnormalities in BD. METHODS: In a sample of 517 individuals (N=121 BD cases, 116 SZ cases, 61 other psychosis cases and 219 healthy controls), we tested the potential association between nine SNPs in the genes CACNA1C, ANK3, ODZ4 and SYNE1 and eight brain structural measures found to be altered in BD, and if these were specifically affecting the BD sample. We also assessed the polygenic effect of all these 9 SNPs on the brain phenotypes. RESULTS: Our most significant result was an association between the risk allele A in CACNA1C SNP rs4775913 and decreased cerebellar volume (pnom.=0.0075) in the total sample, which did not remain significant after multiple testing correction (pthreshold<0.0064). There was no evidence for diagnostic specificity for this association in the BD group. Further, no polygenic effect of these 9 SNPs was observed. LIMITATIONS: Low statistical power might increase our type II error rate. CONCLUSIONS: The present findings indicate that these risk SNPs do not explain a large proportion of the structural brain alterations in BD. Thus, these genes which are all related to neuronal functions must be involved in other pathophysiological aspects of BD development.
BACKGROUND: While recent genome-wide association studies have identified several new bipolar disorder (BD) risk variants, structural imaging studies have reported enlarged ventricles and volumetric reductions among the most consistent findings. We investigated whether these genetic risk variants could explain some of the structural brain abnormalities in BD. METHODS: In a sample of 517 individuals (N=121 BD cases, 116 SZ cases, 61 other psychosis cases and 219 healthy controls), we tested the potential association between nine SNPs in the genes CACNA1C, ANK3, ODZ4 and SYNE1 and eight brain structural measures found to be altered in BD, and if these were specifically affecting the BD sample. We also assessed the polygenic effect of all these 9 SNPs on the brain phenotypes. RESULTS: Our most significant result was an association between the risk allele A in CACNA1C SNP rs4775913 and decreased cerebellar volume (pnom.=0.0075) in the total sample, which did not remain significant after multiple testing correction (pthreshold<0.0064). There was no evidence for diagnostic specificity for this association in the BD group. Further, no polygenic effect of these 9 SNPs was observed. LIMITATIONS: Low statistical power might increase our type II error rate. CONCLUSIONS: The present findings indicate that these risk SNPs do not explain a large proportion of the structural brain alterations in BD. Thus, these genes which are all related to neuronal functions must be involved in other pathophysiological aspects of BD development.
Authors: R Hashimoto; K Ohi; H Yamamori; Y Yasuda; M Fujimoto; S Umeda-Yano; Y Watanabe; M Fukunaga; M Takeda Journal: Curr Mol Med Date: 2015 Impact factor: 2.222
Authors: Alessia Fiorentino; Niamh Louise O'Brien; Devin Paul Locke; Andrew McQuillin; Alexandra Jarram; Adebayo Anjorin; Radhika Kandaswamy; David Curtis; Robert Alan Blizard; Hugh Malcolm Douglas Gurling Journal: Bipolar Disord Date: 2014-04-10 Impact factor: 6.744
Authors: Viola Oertel-Knöchel; Thomas M Lancaster; Christian Knöchel; Michael Stäblein; Helena Storchak; Britta Reinke; Alina Jurcoane; Jonathan Kniep; David Prvulovic; Kiran Mantripragada; Katherine E Tansey; Michael C O'Donovan; Michael J Owen; David E J Linden Journal: Neuroimage Clin Date: 2015-03-13 Impact factor: 4.881
Authors: E T C Lippard; K P Jensen; F Wang; J A Y Johnston; L Spencer; B Pittman; J Gelernter; H P Blumberg Journal: Mol Psychiatry Date: 2016-05-31 Impact factor: 15.992
Authors: D P Hibar; L T Westlye; N T Doan; N Jahanshad; J W Cheung; C R K Ching; A Versace; A C Bilderbeck; A Uhlmann; B Mwangi; B Krämer; B Overs; C B Hartberg; C Abé; D Dima; D Grotegerd; E Sprooten; E Bøen; E Jimenez; F M Howells; G Delvecchio; H Temmingh; J Starke; J R C Almeida; J M Goikolea; J Houenou; L M Beard; L Rauer; L Abramovic; M Bonnin; M F Ponteduro; M Keil; M M Rive; N Yao; N Yalin; P Najt; P G Rosa; R Redlich; S Trost; S Hagenaars; S C Fears; S Alonso-Lana; T G M van Erp; T Nickson; T M Chaim-Avancini; T B Meier; T Elvsåshagen; U K Haukvik; W H Lee; A H Schene; A J Lloyd; A H Young; A Nugent; A M Dale; A Pfennig; A M McIntosh; B Lafer; B T Baune; C J Ekman; C A Zarate; C E Bearden; C Henry; C Simhandl; C McDonald; C Bourne; D J Stein; D H Wolf; D M Cannon; D C Glahn; D J Veltman; E Pomarol-Clotet; E Vieta; E J Canales-Rodriguez; F G Nery; F L S Duran; G F Busatto; G Roberts; G D Pearlson; G M Goodwin; H Kugel; H C Whalley; H G Ruhe; J C Soares; J M Fullerton; J K Rybakowski; J Savitz; K T Chaim; M Fatjó-Vilas; M G Soeiro-de-Souza; M P Boks; M V Zanetti; M C G Otaduy; M S Schaufelberger; M Alda; M Ingvar; M L Phillips; M J Kempton; M Bauer; M Landén; N S Lawrence; N E M van Haren; N R Horn; N B Freimer; O Gruber; P R Schofield; P B Mitchell; R S Kahn; R Lenroot; R Machado-Vieira; R A Ophoff; S Sarró; S Frangou; T D Satterthwaite; T Hajek; U Dannlowski; U F Malt; V Arolt; W F Gattaz; W C Drevets; X Caseras; I Agartz; P M Thompson; O A Andreassen Journal: Mol Psychiatry Date: 2017-05-02 Impact factor: 15.992
Authors: M G Soeiro-de-Souza; B Lafer; R A Moreno; F G Nery; T Chile; K Chaim; C da Costa Leite; R Machado-Vieira; M C G Otaduy; H Vallada Journal: Transl Psychiatry Date: 2017-04-11 Impact factor: 6.222
Authors: Christoph Abé; Predrag Petrovic; William Ossler; William H Thompson; Benny Liberg; Jie Song; Sarah E Bergen; Carl M Sellgren; Peter Fransson; Martin Ingvar; Mikael Landén Journal: J Psychiatry Neurosci Date: 2021-07-22 Impact factor: 6.186